John Dingell actually said...
Do you believe that the clinical trial standards laid out by FDA in the premarket approval process are rigorous enough to prove safety and effectiveness of class III devices?
Context
Dingell questions the adequacy of FDA's clinical trial standards for class III devices.
07/19/2011